[Antibiotic prophylaxis reduces the incidence of infection and mortality in patients with necrotizing pancreatitis?].
Aires
Felipe Toyama
FT
Faculdade de Medicina de Santos, UNILUS, Santos, SP.
Bernardo
Wanderley Marques
WM
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D019072:Antibiotic Prophylaxis; D001424:Bacterial Infections / Q000517:prevention & control*; D002939:Ciprofloxacin / Q000627:therapeutic use; D018450:Disease Progression; D006801:Humans; D015378:Imipenem / Q000627:therapeutic use; D000077731:Meropenem; D008795:Metronidazole / Q000627:therapeutic use; D019283:Pancreatitis, Acute Necrotizing / Q000401:mortality* / Q000517:prevention & control*; D013845:Thienamycins / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D013845:Thienamycins; D008795:Metronidazole; D002939:Ciprofloxacin; D015378:Imipenem; D000077731:Meropenem